Thomas Hubka - Histogen Director Sec

HSTODelisted Stock  USD 0.03  0.00  0.00%   

Insider

Thomas Hubka is Director Sec of Histogen
Age 36
Phone858 526 3100
Webhttps://www.histogen.com

Histogen Management Efficiency

The company has return on total asset (ROA) of (0.5381) % which means that it has lost $0.5381 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1989) %, meaning that it created substantial loss on money invested by shareholders. Histogen's management efficiency ratios could be used to measure how well Histogen manages its routine affairs as well as how well it operates its assets and liabilities.
Histogen currently holds 4.63 M in liabilities with Debt to Equity (D/E) ratio of 0.31, which is about average as compared to similar companies. Histogen has a current ratio of 12.96, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Histogen's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Susan DexterSonnet Biotherapeutics Holdings
70
James CollinsSenti Biosciences
58
Sharon McBrayerPalisade Bio
N/A
Miranda MBAEntera Bio
48
Emer MBABright Minds Biosciences
59
Gideon ShapiroBright Minds Biosciences
N/A
Craig EsqCingulate
51
John CiniSonnet Biotherapeutics Holdings
73
MD FAAAAIPalisade Bio
N/A
II MDEntera Bio
71
Seth MDTonix Pharmaceuticals Holding
67
Petpiboon PrasitTempest Therapeutics
N/A
RAC SakaiTempest Therapeutics
N/A
Daniel MDTonix Pharmaceuticals Holding
N/A
Anne MoonTempest Therapeutics
N/A
Hillel MBAEntera Bio
47
Gregory MBAArtelo Biosciences
62
CPA CPATonix Pharmaceuticals Holding
50
Robert McRaePalisade Bio
N/A
Manuel DafonsecaSonnet Biotherapeutics Holdings
N/A
Steven ReichArtelo Biosciences
78
Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. Histogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. Histogen (HSTO) is traded on NASDAQ Exchange in USA and employs 7 people.

Management Performance

Histogen Leadership Team

Elected by the shareholders, the Histogen's board of directors comprises two types of representatives: Histogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Histogen. The board's role is to monitor Histogen's management team and ensure that shareholders' interests are well served. Histogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Histogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Stephen Hill, VP Controller
Steven Mento, Interim Chairman
Thomas Hubka, Director Sec
Gail Naughton, Founder Advisor
Susan Knudson, CEO, President

Histogen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Histogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Histogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Histogen Stock

  0.81PKX POSCO HoldingsPairCorr

Moving against Histogen Stock

  0.87BA BoeingPairCorr
  0.77PFE Pfizer Inc Aggressive PushPairCorr
  0.52MMM 3M CompanyPairCorr
  0.51CSCO Cisco SystemsPairCorr
  0.39JPM JPMorgan ChasePairCorr
The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.
The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Histogen Stock

If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Valuation
Check real value of public entities based on technical and fundamental data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk